尿液检查市场规模、份额、成长分析、按产品类型、按应用、按地区 - 行业预测，2024-2031

2022年全球尿液检查市场规模为39亿美元，从2023年的42.8亿美元成长到2031年的89.7亿美元，预计复合年增长率为9.70%。

全球尿液检查市场在医疗保健领域正在迅速扩大。尿液检查或尿液检查透过分析尿液样本来诊断各种医疗状况并监测整体健康状况。这种诊断工具对于早期疾病检测和管理至关重要，并已成为世界各地医疗保健机构的主要工具。技术和检测方法的进步极大地提高了尿液检查的准确性、效率和可靠性，增加了其在医院、诊所、诊断实验室和居家医疗机构中的使用。推动尿液检查市场成长的因素有很多。尿道感染、肾臟疾病和其他泌尿器官系统疾病的发生率上升是主要驱动因素。此外，老年人口的不断增长以及糖尿病、高血压等慢性病的盛行率不断增加，对常规尿液检查的需求也随之增加。此外，从传统的手动测试到自动化照护现场(POC) 系统的转变将提高测试的速度和便利性，使医疗保健专业人员能够做出及时、明智的决策。市场竞争激烈，许多公司正在投资研发以推出创新产品和技术。主要企业正在寻求产品发布、合併、收购、联盟和策略伙伴关係，以提高其市场占有率和竞争力。总体而言，由于技术进步以及对早期疾病检测和持续健康监测的需求不断增加，全球尿液检查市场预计将持续成长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• 贸易分析
• 供应链分析
• 案例研究分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

尿液检查市场：按产品

• 市场概况
• 消耗品
  • 怀孕/不孕症治疗套件
  • 量油尺
  • 试剂
  • 一次性的
• 装置
  • 自动尿液分析仪
  • 一体化尿液分析仪
  • 尿液沉渣分析仪
  • 流式细胞技术分析仪
  • 显微镜分析仪
  • 尿液生化分析仪
  • 半自动尿液分析仪
  • 照护现场尿液分析仪

尿液检查市场：按测试类型

• 市场概况
• 妊娠及不孕症检测
• 生物化学检验
  • 临床检查
  • POC测试
• 尿液检查

尿液检查市场：依应用分类

• 市场概况
• 疾病筛检
  • 尿道感染
  • 肾臟疾病
  • 糖尿病
  • 肝臟疾病
  • 其他的
• 妊娠及不孕症检测

尿液检查市场：依最终用户分类

• 市场概况
• 诊断实验室
• 医院/诊所
• 居家照护环境
• 研究实验室/研究机构

尿液检查市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Cardinal Health（US）
• Danaher（US）
• Abbott（US）
• Sysmex Corporation（Japan）
• Thermo Fisher Scientific Inc.（US）
• QuidelOrtho Corporation（US）
• Becton, Dickinson and Company（US）
• Bio-Rad Laboratories, Inc.（US）
• EKF Diagnostics Holdings PLC（UK）
• Arkray, Inc.（Japan）
• ACON Laboratories, Inc.（US）
• 77 Elektronika Kft.（Hungary）
• URIT Medical Electronic Co., Ltd.（China）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
• Dirui Industrial Co., Ltd.（China）
• BIOBASE Group（China）
• Erba Mannheim（Germany）
• Alphatec Scientific EIRL（Peru）
• Teco Diagnostics（US）
• Analyticon Biotechnologies GmbH（Germany）
• Bioway Biological Technology Co., Ltd.（China）
• High Technology, Inc.（US）
• Agappe Diagnostics Ltd（India）
• Toyobo Co., Ltd.（Japan）
• DIALAB GmbH（Austria）
• Quantimetrix（US）
• Biocare Corporation（Taiwan）
• Randox Laboratories Ltd.（UK）
• PZ Cormay SA（Poland）
• YD Diagnostics（South Korea）
• Contec Medical Systems Co., Ltd.（China）
• Biopanda Reagents Ltd.（UK）

Global Urinalysis Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.28 billion in 2023 to USD 8.97 billion by 2031, growing at a CAGR of 9.70% during the forecast period (2024-2031).

The global urinalysis market is rapidly expanding within the healthcare sector. Urinalysis, or urine testing, involves analyzing urine samples to diagnose various medical conditions and monitor general health. This diagnostic tool is crucial for the early detection and management of diseases, making it a staple in healthcare settings worldwide. Advances in technology and testing methods have significantly enhanced the accuracy, efficiency, and reliability of urinalysis, leading to its increased use in hospitals, clinics, diagnostic labs, and homecare environments. Several factors are fueling the growth of the urinalysis market. The rising incidence of urinary tract infections, kidney diseases, and other urological disorders is a major driver. Additionally, the growing elderly population and the higher prevalence of chronic conditions like diabetes and hypertension have increased the demand for routine urine testing. The transition from traditional manual testing to automated and point-of-care urinalysis systems has also improved the speed and convenience of testing, allowing healthcare professionals to make timely and informed decisions. The market is highly competitive, with many companies investing in research and development to introduce innovative products and technologies. Key players are pursuing product launches, mergers, acquisitions, collaborations, and strategic partnerships to enhance their market presence and competitive edge. Overall, the global urinalysis market is poised for continued growth, driven by technological advancements and the increasing need for early disease detection and ongoing health monitoring.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Market Segmental Analysis

Global Urinalysis Market is segmented by Product, Test Type, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Test Type, the market is segmented into Pregnancy & Fertility Tests, Biochemical Tests, and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening, and Pregnancy & Fertility Testing. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Urinalysis Market

A key driver of market growth is the increasing incidence of urinary tract infections (UTIs) in developing countries. This rising prevalence significantly impacts the market, as untreated UTIs can progress to affect the kidneys and lead to complications during pregnancy. The market's expansion is largely fueled by the potential severity of UTIs if left untreated. Complications such as kidney infections and adverse effects on pregnant women underscore the urgent need for effective diagnostic and treatment solutions, further propelling market development.

Restraints in the Global Urinalysis Market

The availability of reconditioned urine analyzers is expected to limit the market's growth during the forecast period. These devices, while cost-effective, may impact the demand for new, advanced analyzers, thereby constraining market expansion. Additionally, potential changes in regulatory environments could further challenge the growth of the urinalysis industry. Stricter regulations or altered oversight requirements might complicate market conditions and hinder future development.

Market Trends of the Global Urinalysis Market

The demand for point-of-care urinalysis testing is increasing, driven by its ability to deliver rapid, on-site diagnoses. This approach allows healthcare professionals to obtain immediate results, which supports quicker decision-making and enhances patient outcomes. Point-of-care testing is valued for its efficiency and convenience, offering real-time data that helps streamline clinical processes and improve overall patient care. The ability to conduct tests and receive results on the spot is becoming increasingly important in various healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Urinalysis Market by Product

• Market Overview
• Consumables
  • Pregnancy & Fertility Kits
  • Dipsticks
  • Reagents
  • Disposables
• Instruments
  • Automated Urine Analyzers
  • Integrated urine analyzers
  • Sediment urine analyzers
  • Flow cytometry analyzers
  • Microscopy analyzers
  • Biochemical urine analyzers
  • Semi-automated Urine Analyzers
  • Point-of-care Urine Analyzers

Urinalysis Market by Test Type

• Market Overview
• Pregnancy & Fertility Tests
• Biochemical Tests
  • Laboratory Tests
  • POC Tests
• Sediment Urinalysis

Urinalysis Market by Application

• Market Overview
• Disease Screening
  • Urinary Tract Infections
  • Kidney Diseases
  • Diabetes
  • Liver Diseases
  • Others
• Pregnancy & Fertility Testing

Urinalysis Market by End User

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Home Care Settings
• Research Laboratories & Institutes

Urinalysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electronic Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dirui Industrial Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOBASE Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Mannheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alphatec Scientific E.I.R.L. (Peru)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teco Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analyticon Biotechnologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioway Biological Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• High Technology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agappe Diagnostics Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toyobo Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIALAB GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantimetrix (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PZ Cormay S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• YD Diagnostics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contec Medical Systems Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments